摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Chromyl chloride | 14977-61-8

中文名称
——
中文别名
——
英文名称
Chromyl chloride
英文别名
chromium(6+);oxygen(2-);dichloride
Chromyl chloride化学式
CAS
14977-61-8
化学式
Cl2CrO2
mdl
——
分子量
154.9
InChiKey
AKNPEMSZIKCOGC-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    -96.5 °C (lit.)
  • 沸点:
    117 °C (lit.)
  • 密度:
    1.911 g/mL at 25 °C (lit.)
  • 闪点:
    117°C
  • 溶解度:
    与H2O反应;溶于四氯化碳、氯仿、苯
  • 暴露限值:
    ACGIH: TWA 0.0001 ppm; STEL 0.00025 ppm (Skin)NIOSH: TWA 0.0002 mg/m3
  • 介电常数:
    2.6(20℃)
  • 物理描述:
    DARK RED FUMING LIQUID WITH PUNGENT ODOUR.
  • 颜色/状态:
    Deep red liquid; appears black under reflected light
  • 气味:
    Pungent odor
  • 蒸汽密度:
    Relative vapor density (air = 1): 5.3
  • 蒸汽压力:
    19.6 mm Hg at 25 °C
  • 稳定性/保质期:

    Stable under recommended storage conditions.

  • 分解:
    When heated to decomposition it emits toxic fumes of /hydrogen chloride/.
  • 粘度:
    Slightly less viscous than water
  • 腐蚀性:
    Will cause severe corrosion of common metals.
  • 汽化热:
    113 Btu/lb = 62.6 cal/g = 2.62X10+5 J/kg
  • 表面张力:
    36.61 dynes/cm = 0.03661 N/m at 19 °C
  • 电离电位:
    12.60 eV

计算性质

  • 辛醇/水分配系数(LogP):
    -6.23
  • 重原子数:
    5
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    2
  • 氢给体数:
    0
  • 氢受体数:
    4

ADMET

毒理性
  • 致癌性证据
证据权重特征:根据当前指南(1986年),六价被归类为A组——已知的人类通过吸入途径的致癌物。通过口服途径的致癌性无法确定,被归类为D组。在拟议的指南(1996年)下,六价将被定性为通过吸入途径的已知人类致癌物,基于以下原因。已知六价通过吸入途径在人类中具有致癌性。对接触的工人进行的职业流行病学研究结果在不同的研究者和研究人群之间是一致的。已经建立了暴露与肺癌的剂量-反应关系。接触的工人既暴露于三价也暴露于六价化合物。然而,只有六价在动物研究中被发现的具有致癌性,因此得出结论,只有六价应该被归类为人类致癌物。动物数据与六价的人类致癌性数据一致。六价化合物在动物生物测定中具有致癌性,产生以下肿瘤类型:大鼠和小鼠的肌肉内注射部位肿瘤,各种六价化合物在大鼠的胸膜内植入部位肿瘤,各种六价化合物在大鼠的支气管内植入部位肿瘤,以及大鼠的皮下注射部位肉瘤。体外数据提示六价致癌性的潜在作用模式。六价的致癌性可能是由于细胞内还原为三价形式后形成致突变氧化DNA损伤。六价容易通过细胞膜并迅速在细胞内还原,生成反应性的三价和四价中间体和活性氧种。在六价还原过程中形成许多潜在的致突变DNA损伤。六价在细菌测定、酵母和V79细胞中具有致突变性,六价化合物降低了体外DNA合成的准确性,并因DNA损伤产生非计划性DNA合成。铬酸盐已被证明能转化原代细胞和细胞系。 人类致癌性数据:对化合物的职业暴露已经在铬酸盐生产、镀颜料生产、矿开采、皮革鞣制和生产行业进行了研究。铬酸盐行业的工人暴露于三价和六价的化合物。对日本、英国、西德和美国的铬酸盐生产厂进行的流行病学研究揭示了职业接触与肺癌之间的相关性,但没有确定引起癌症的具体形态......颜料工人的研究一致表明,职业暴露(主要是六价)与肺癌有关。对镀行业进行的几项研究表明,癌症与接触化合物之间存在正相关关系。 动物致癌性数据:动物数据与六价的人类流行病学研究结果一致...... /六价/
WEIGHT OF EVIDENCE CHARACTERIZATION: Under the current guidelines (1986), Cr(VI) is classified as Group A - known human carcinogen by the inhalation route of exposure. Carcinogenicity by the oral route of exposure cannot be determined and is classified as Group D. Under the proposed guidelines (1996), Cr(VI) would be characterized as a known human carcinogen by the inhalation route of exposure on the following basis. Hexavalent chromium is known to be carcinogenic in humans by the inhalation route of exposure. Results of occupational epidemiological studies of chromium-exposed workers are consistent across investigators and study populations. Dose-response relationships have been established for chromium exposure and lung cancer. Chromium-exposed workers are exposed to both Cr(III) and Cr(VI) compounds. Because only Cr(VI) has been found to be carcinogenic in animal studies, however, it was concluded that only Cr(VI) should be classified as a human carcinogen. Animal data are consistent with the human carcinogenicity data on hexavalent chromium. Hexavalent chromium compounds are carcinogenic in animal bioassays, producing the following tumor types: intramuscular injection site tumors in rats and mice, intrapleural implant site tumors for various Cr(VI) compounds in rats, intrabronchial implantation site tumors for various Cr(VI) compounds in rats and subcutaneous injection site sarcomas in rats. In vitro data are suggestive of a potential mode of action for hexavalent chromium carcinogenesis. Hexavalent chromium carcinogenesis may result from the formation of mutagenic oxidatitive DNA lesions following intracellular reduction to the trivalent form. Cr(VI) readily passes through cell membranes and is rapidly reduced intracellularly to generate reactive Cr(V) and Cr(IV) intermediates and reactive oxygen species. A number of potentially mutagenic DNA lesions are formed during the reduction of Cr(VI). Hexavalent chromium is mutagenic in bacterial assays, yeasts and V79 cells, and Cr(VI) compounds decrease the fidelity of DNA synthesis in vitro and produce unscheduled DNA synthesis as a consequence of DNA damage. Chromate has been shown to transform both primary cells and cell lines. HUMAN CARCINOGENICITY DATA: Occupational exposure to chromium compounds has been studied in the chromate production, chromeplating and chrome pigment, ferrochromium production, gold mining, leather tanning and chrome alloy production industries. Workers in the chromate industry are exposed to both trivalent and hexavalent compounds of chromium. Epidemiological studies of chromate production plants in Japan, Great Britain, West Germany, and the United States have revealed a correlation between occupational exposure to chromium and lung cancer, but the specific form of chromium responsible for the induction of cancer was not identified ... Studies of chrome pigment workers have consistently demonstrated an association between occupational chromium exposure (primarily Cr(VI)) and lung cancer. Several studies of the chromeplating industry have demonstrated a positive relationship between cancer and exposure to chromium compounds. ANIMAL CARCINOGENICITY DATA: Animal data are consistent with the findings of human epidemiological studies of hexavalent chromium ... /Chromium (VI)/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
评估:有足够的人类证据表明六价化合物具有致癌性。六价化合物可导致肺癌。此外,还观察到暴露于四价化合物与鼻咽癌之间存在正相关关系。有足够的实验动物证据表明六价化合物具有致癌性。六价化合物对人类具有致癌性(第1组)。/六价化合物/
Evaluation: There is sufficient evidence in humans for the carcinogenicity of chromium(VI) compounds. Chromium(VI) compounds cause cancer of the lung. Also positive associations have been observed between exposure to Chromium(IV) compounds and cancer of the nose and nasal sinuses. There is sufficient evidence in experimental animals for the carcinogenicity of chromium(VI) compounds. Chromium(VI) compounds are carcinogenic to humans (Group 1). /Chromium(VI) compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
hexavalent 化合物:已知是人类致癌物。/ hexavalent 化合物/
Chromium Hexavalent Compounds: known to be human carcinogens. /Chromium hexavalent compound/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
A1; 确认的人类致癌物。/溶性(VI)无机化合物/
A1; Confirmed human carcinogen. /Water-soluble Cr(VI) inorganic compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
A1; 确认的人类致癌物。/不溶性(VI)无机化合物/
A1; Confirmed human carcinogen. /Insoluble Cr(VI) inorganic compounds/
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 职业暴露等级:
    E
  • 职业暴露限值:
    TWA: 0.001 mg Cr(VI)/m3
  • TSCA:
    Yes
  • 危险等级:
    8
  • 危险品标志:
    O,T,N
  • 安全说明:
    S45,S53,S60,S61
  • 危险类别码:
    R49,R8,R43,R35,R50/53,R46
  • WGK Germany:
    3
  • RTECS号:
    GB5775000
  • 海关编码:
    2914700090
  • 包装等级:
    I
  • 危险类别:
    8
  • 危险品运输编号:
    UN 3244 8/PG 2
  • 危险标志:
    GHS03,GHS05,GHS07,GHS08,GHS09
  • 危险性描述:
    H271,H314,H317,H340,H350i,H410
  • 危险性防范说明:
    P201,P210,P273,P280,P303 + P361 + P353,P305 + P351 + P338

SDS

SDS:9d4b52c4dc27b45a560c693622876df2
查看

制备方法与用途

生产方法
  1. 将150g三氧化铬溶于100mL中,加入330mL浓盐酸,并用冷冻剂冷却至0℃。在搅拌下滴入450mL浓硫酸。此时,溶液的温度应保持在10℃以下。反应结束后,将溶液注入分液漏斗中,分离并储存下层部分,收率可达189g(81%)。

  2. 安装精馏装置,并对上述溶液进行分馏,收集115~116℃(0.9796×10^5 Pa)的馏分(为粗制品的65%)。保存时应通入干燥空气以完全逐出氯化氢,然后进行蒸馏并封入安瓿中,置于暗处储存。

由于生成物可能侵蚀磨口的润滑脂,造成润滑脂固化使磨口处活动受阻,建议采用聚四氟乙烯等无润滑脂的磨口。

类别
  • 腐蚀物品
可燃性危险特性 储运特性
  • 库房应通风、低温干燥;需与碱类、食品添加剂分开存放
灭火剂
  • 干砂、干石粉;禁止用
职业标准
  • TLV-TWA 0.025 PPM; TWA 0.5 毫克 ()/立方米